1. Home
  2. CRGX vs CCRN Comparison

CRGX vs CCRN Comparison

Compare CRGX & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • CCRN
  • Stock Information
  • Founded
  • CRGX 2021
  • CCRN 1986
  • Country
  • CRGX United States
  • CCRN United States
  • Employees
  • CRGX N/A
  • CCRN N/A
  • Industry
  • CRGX
  • CCRN Professional Services
  • Sector
  • CRGX
  • CCRN Consumer Discretionary
  • Exchange
  • CRGX Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • CRGX 628.6M
  • CCRN 587.1M
  • IPO Year
  • CRGX 2023
  • CCRN N/A
  • Fundamental
  • Price
  • CRGX $3.70
  • CCRN $18.19
  • Analyst Decision
  • CRGX Hold
  • CCRN Buy
  • Analyst Count
  • CRGX 7
  • CCRN 3
  • Target Price
  • CRGX $4.67
  • CCRN $18.31
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • CCRN 431.7K
  • Earning Date
  • CRGX 03-20-2025
  • CCRN 02-19-2025
  • Dividend Yield
  • CRGX N/A
  • CCRN N/A
  • EPS Growth
  • CRGX N/A
  • CCRN N/A
  • EPS
  • CRGX N/A
  • CCRN N/A
  • Revenue
  • CRGX N/A
  • CCRN $1,448,099,000.00
  • Revenue This Year
  • CRGX N/A
  • CCRN N/A
  • Revenue Next Year
  • CRGX N/A
  • CCRN N/A
  • P/E Ratio
  • CRGX N/A
  • CCRN N/A
  • Revenue Growth
  • CRGX N/A
  • CCRN N/A
  • 52 Week Low
  • CRGX $3.00
  • CCRN $9.58
  • 52 Week High
  • CRGX $33.92
  • CCRN $21.41
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • CCRN 71.82
  • Support Level
  • CRGX $3.00
  • CCRN $18.17
  • Resistance Level
  • CRGX $3.88
  • CCRN $18.26
  • Average True Range (ATR)
  • CRGX 0.92
  • CCRN 0.06
  • MACD
  • CRGX -1.00
  • CCRN -0.13
  • Stochastic Oscillator
  • CRGX 5.99
  • CCRN 50.00

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: